Multiple site testing evaluation, Lancing device. ascensia c, Ontour – Bayer HealthCare Ascensia Contour Blood Glucose Monitoring System User Manual

Page 38: Icrolet, Aculance

Advertising
background image

Multiple Site Testing Evaluation

Forty persons with diabetes, in steady state for glucose,
performed self-capillary blood glucose assays using the
Ascensia C

ONTOUR

System and one reagent lot. A fingerstick

was performed with the Microlet Adjustable Lancing Device.
Samples from the palm, forearm, thigh, and abdomen were
obtained using the Ascensia™ M

ICROLET

V

ACULANCE

®

Lancing

Device. Ascensia C

ONTOUR

results from the multiple sites were

compared to those obtained from the finger. One subject was
unable to obtain a sample from the abdomen. The blood
glucose range from the fingerstick measurements was 49 to
407 mg/dL, with an average of 166 mg/dL. The hematocrit
range was 36 to 52%, with an average of 42%.

34

0

100

200

300

400

500

600

0

100

200

300

400

500

600

0

100

200

300

400

500

600

0

100

200

300

400

500

600

Ascensia

C

ONTOUR

Palm Result (mg/dL)

Ascensia

C

ONTOUR

Fingerstick Result (mg/dL)

Ascensia

C

ONTOUR

Fingerstick Result (mg/dL)

y=x

Ascensia

C

ONTOUR

Forearm Result (mg/dL)

y=x

A. Results from the Palm

B. Results from the Forearm

Advertising